Stay updated on EPCORE™ NHL-1 Clinical Trial
Sign up to get notified when there's something new on the EPCORE™ NHL-1 Clinical Trial page.

Latest updates to the EPCORE™ NHL-1 Clinical Trial page
- Check3 days agoChange DetectedPage revision updated to v3.0.2, replacing v3.0.1. The Back to Top element was removed.SummaryDifference0.1%
- Check10 days agoChange DetectedThe page has been updated to reflect a new version (v3.0.1) and includes new dates for updates, replacing the previous version's dates.SummaryDifference0.4%
- Check17 days agoChange DetectedThe webpage has been updated to include new facility names and locations, particularly in South Korea and Poland, as well as detailed drug information regarding Epcoritamab and related studies. Several previous location terms and related topics have been removed.SummaryDifference13%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.4%
- Check39 days agoChange DetectedThe webpage has been updated to reflect new dates in August 2025 and has been revised to version 2.16.11.SummaryDifference0.4%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to EPCORE™ NHL-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPCORE™ NHL-1 Clinical Trial page.